Illumina (ILMN) reported $1.08 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 0.4%. EPS of $1.34 for the same period compares to $1.14 a year ago.

Wall Street analysts forecast that Illumina (ILMN) will report quarterly earnings of $0.87 per share in its upcoming release, pointing to a year-over-year increase of 163.6%. It is anticipated that ...

Abstract: Image based Microarray processing has been widely applied to the biotechnology field for identifying SNP variations. In order to reduce the cost for manufacturers, a flexible design for ...

Table 9: Global Microarray Analysis Market, by End User, $Million Table 10: Global Microarray Analysis Market (by Product), $Million, 2022-2033 Table 11: Global ...

Tissue microarrays combines tens to hundreds of paraffin-embedded tissue cores into a single paraffin block. It is a practical and highly effective technique for high-throughput analyses of various ...

Thermo Fisher Scientific launched a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency, and profitability with a two-day turnaround time. Providing ...